Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -7.34 % |
3 Month Return | + 15.22 % |
1 Year Return | + 25.78 % |
Market Stats | |
Previous Close | ₹463.30 |
Open | ₹479.95 |
Volume | 4,190.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹143.16Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹143.16 Cr |
P/B Ratio | 1.59 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 3.37 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹143.16 Cr | 73.55% | 0.56 | NA | NA | |
NA | ₹64.17 Cr | 258.28% | 0.50 | NA | NA | |
NA | ₹123.98 Cr | 53.7% | 0.69 | NA | NA | |
NA | ₹94.27 Cr | 188.71% | 0.51 | NA | NA | |
NA | ₹1,388.42 Cr | 84.92% | 0.51 | ₹25 Cr | ₹212 Cr |
Organisation | Samrat Pharmachem Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Samrat Pharmachem Ltd
Samrat Pharmachem reports strong Q4 results with a 19.77% increase in revenue and ₹1.4cr profit compared to a loss of ₹0.74cr in the previous year. The EPS is ₹4.52 for Q4, up by 287.52% YoY.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
Promoters have increased holdings from 48.64% to 48.95% in Sep 2024 quarter
Price Rise
In the last 3 months, Samrat Pharma stock has moved up by 15.2%
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 130.6% return, outperforming this stock by 36.3%
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 58.6% return, outperforming this stock by 32.8%
Retail Holding Down
Retail Investor have decreased holdings from 47.91% to 47.59% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 48.95% | 0.65 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 47.59% | ||
Others | 3.45% | 0.00 |
Samrat Pharmachem Ltd’s net profit jumped 1500% since last year same period to ₹2.66Cr in the Q2 2024-2025. On a quarterly growth basis, Samrat Pharmachem Ltd has generated 28.5% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Samrat Pharmachem Ltd has declared dividend of ₹1 - translating a dividend yield of 0.43%.
Read More about DividendsBearish
Neutral
Bullish
Samrat Pharmachem Ltd is currently in a Bearish trading position according to technical analysis indicators.
Samrat Pharmachem Ltd (530125) share price today is ₹445
Samrat Pharmachem Ltd is not listed on NSE
Samrat Pharmachem Ltd is listed on BSE
Today’s traded volume of Samrat Pharmachem Ltd(530125) is 4,190.00.
Today’s market capitalisation of Samrat Pharmachem Ltd(530125) is ₹143.16Cr.
Samrat Pharmachem Ltd(530125 | Price |
---|---|
52 Week High | ₹646 |
52 Week Low | ₹320 |
Samrat Pharmachem Ltd(530125) share price is ₹445. It is down -31.11% from its 52 Week High price of ₹646
Samrat Pharmachem Ltd(530125) share price is ₹445. It is up 39.06% from its 52 Week Low price of ₹320
Samrat Pharmachem Ltd(530125 | Returns |
---|---|
1 Day Returns | -18.3% |
1 Month Returns | -7.34% |
3 Month Returns | 15.22% |
1 Year Returns | 25.78% |